US seeks EU API import exemption

The US FDA has formally requested to be listed as a third country with GMP rules equivalent to those in the EU to meet the EU's strengthened rules for import of APIs. The FDA said that if its listing request is approved then US exporters will avoid duplicative administrative efforts, which could impede trade and delay the manufacture of needed medicines.
In-pharma Technologist